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ABSTRACT
A series of deletion mutants in the recently identified bactobolinbiosynthetic pathway defined the roles of several key biosynthetic enzymes and
showed how promiscuity in three enzyme systems allows this cluster to produce multiple products. Studies on the deletion mutants also led to
four new bactobolin analogs that provide additional structure activity relationships for this interesting antibiotic family.
The proteobacterial genus Burkholderia contains signif-
icant plant and animal pathogens including B. pseudo-
mallei and B. mallei, the causative agents of meliodosis
(Whitmore disease) in humans and glanders in horses.
1
B. thailandensis, a nonvirulent member of the genus, has
become a model organism in which to study factors control-
ling both virulence and the expression of secondary metab-
olites.
2 The completed genome sequence of B. thailandensis
contains at least a dozen polyketide synthase (PKS) and/or
nonribosomal peptide synthetase (NRPS) biosynthetic clus-
ters,butonlythreeoftheseclustershavebeenassociatedwith
their corresponding small molecule products.
3 This report
describes combined genetic and metabolomic studies that
refine our understanding of the biosynthesis of members of
the bactobolin antibiotic family in B. thailandensis.
Our interest in the bactobolins originated in studies by
Duerkop et al. showing that N-acylhomoserine lactones,
the typical quorum sensing signals in proteobacteria,
4
initiate the synthesis of a potent antibiotic.
5 This study
also identified the biosynthetic locus (bta) of bactobolin.
Later work by Seyedsayamdost et al. identified the pro-
ducts of the bta cluster as bactobolins (Figure 1, 1 4)a n d
provided a clearer picture of the bta biosynthetic locus
(Figure 2A) as well as a tentative model for bactobolin
biosynthesis (Figure 2B).
3c
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In this model, the bactobolin core is built using NRPS
and PKS modules to link substrates and an aldol con-
densationtoclosethecarbocyclicring(Figure2B).
3cBtaK,
an NRPS with an Ala-specific adenylation (A) domain,
generates a dialanyl thioester, and BtaN, also an NRPS,
adds an 3-hydroxy-4,4-dichlorovaline group (OH-Cl2-Val),
which is synthesized by the dichlorinase BtaC, and hydro-
xylated by either BtaA or BtaU, putative Fe-dependent
hydroxylases.
6 These enzymes may use BtaB and/or BtaD,
whicharefree-standingthiolation(T)domainsforsubstrate
tethering (Figure 2A). The resulting tripeptide (10)i st r a n s -
ferred to a PKS assembly line, where BtaOML then adds
three acetyl units derived from malonyl CoA, and BtaL
likely catalyzes an aldol condensation followed by reduc-
tion of the resulting unsaturated ketone 11.F i n a l l y ,e i t h e r
BtaS, a putative type II thioesterase, or BtaP, a predicted
β-lactamase,
7 catalyzes lactone formation to produce 4.
This model has several ambiguities, and in an effort to
further refine it, four markerless deletion strains;BtaB,
BtaL’s short chain dehydrogenase (SDR) domain, BtaP,
and BtaU (Figure 2A);of B. thailandensis were con-
structed using methods previously reported.
8
BtaB and BtaD have a sequence similarity to stand-
alone T domains, though the former has a modified
signature sequence for this class of enzymes.
9 The BtaB
deletionmutantwasgeneratedtoidentifywhichoftheseT
domains is used in bactobolin production as this knowl-
edge would facilitate future in vitro studies of the enzymes
involved in valine modification. The metabolic profile of
the BtaB mutant was very similar to that of wt B. thailan-
densis. It produced all four bactobolins with yields similar
towt(FigureS1,SupportingInformation).Thisresultand
thepredictionsbasedonsequenceanalysisbotharguethat
BtaD is likely the active T domain in valine modification
(Figure 2).
BtaL contains a short chain dehydrogenase (SDR)
domain that was the most likely candidate to carry out
reduction of the aldol condensation product (11).
10 The
SDR domain in BtaL was deleted using the identifiable
linker regions between the AT and ACP domains in BtaL
(Figure 2A) with the optimistic expectation that this
mutant would allow intermediates to accumulate that
could be structurally characterized. However, the SDR
deletioninBtaLcompletelyabrogatedbactobolinproduc-
tionand metabolomic analysisshowed no small molecules
with the isotopic signature for one or two Cl atoms.
BtaPseemedlikelytobeinvolvedinlactoneformation.
7
Itsdeletion,liketheBtaLSDRdomaindeletionstrain,also
completely abrogated bactobolin production (data not
shown). The results from the BtaL and BtaP deletion
strains are consistent with both playing important roles
in bactobolin biosynthesis, as indicated by the model, but
the lack of isolable intermediates prevents a definitive
assignment of function. However, comparison between
the BtaP/BtaL deletion strains and wt did reveal that the
wtstrainproducedfourothercompoundswith[MþH]
þat
m/z 333, 404, 509, and 525 (Figure S2, Supporting Infor-
mation). Their isotopic distribution was consistent with
the presence of chlorine atoms, and the retention times
suggestedthattheywererelatedtotheknownbactobolins.
Thus, while the BtaL and BtaP mutants failed to accumu-
late biosynthetic intermediates, they revealed four unsus-
pected bactobolin analogs from wt B. thailandensis.
Bysequencehomology,BtaUwaslikelyaFe-dependent
hydroxylase, but whether it installed the hydroxyl function
in the modified valine or at C-5 of the bactobolin skeleton
w a su n c l e a r .I nc o n t r a s tt ow tB. thailandensis,t h eB t a U
mutant produced only the nonhydroxylated analogs 3 and
4, but not 1 and 2 (Figures 1 and 3A), indicating that BtaU
is the bactobolin hydroxylase (Figure 3B). Together, the
BtaBandBtaUdeletionstudiesallowustorefineourmodel
for the biosynthesis of OH-Cl2-Val and OH-Cl-Val (see
below), in which BtaD is the active T domain, BtaC the
chlorinase,andBtaAthelikelyhydroxylase(Figure3C).
11,12
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their tentative identification as the dechloro analogs 7 and
8 (Figure 1).
In order to confirm the structures of 5 8, production
culturesofB.thailandensisE264weregrowninaliquidLB
medium for 24 h at 30 C. The spent medium was
fractionatedusingHP-20andHypercarbchromatography
and reversed-phase HPLC (Supporting Information) to
give the new analogs 5 8, along with the known bactobo-
lins 1 4. Analysis of the HR-ESI-MS(þ) and 1D and
2D NMR data for 5 8 (Tables S1 S4, Figures S3 S6,
Supporting Information) confirmed their predicted struc-
tures (Figure 1). Comparison of the NMR data for 5 8
withthe NMR datafor 1 4alsoconfirmedthattheyhave
the same relative configuration. The absolute configura-
tions of the alanine residues in 5 8 were determined by
acid hydrolysis followed by Marfey’s analysis
13 and in-
dicated L-alanine in each case.
Thepresenceofthetrialaninebactobolinanalogs5and6
suggests that the N-terminal C
0-domain in BtaK is active,
or that the module generated by the C-domain in BtaK
andthe N-terminalATdomains inBtaN,whichisrespon-
sible for inserting the second alanine, acts iteratively to
introduce a third Ala residue (Figure 2A).
3c Such domain
and module reuse, and skipping, has been documented in
several modular NRPS systems recently.
14 We were
unable to see any evidence for the corresponding tetra
(or higher)-peptides in the HPLC-MS profile. Once
generated, the putative oligopeptidase (BtaJ) may act
on the trialanine bactobolins to the give corresponding
mono- and dialanine derivatives.
15 This reaction may be
preceded by acetylation of the N-terminal alanine via
the putative acetyltransferase BtaQ, as previously
proposed.
3c,15 Biochemical studies will be necessary to
distinguish between the mechanisms above.
Compounds 7 and 8 contain the unnatural amino acid
3-hydroxy-4-chlorovaline (Cl-Val) in place of 3-hydroxy-
4,4-dichlorovaline (Cl2-Val). The structures of the mono-
chlorinated bactobolin analogs 7 and 8 have implications
for the specificity of the bactobolin hydroxylase, BtaU,
that incorporates the hydroxyl group at C-5 in 1 and 2
(Figure3B).Amongtheknowndichlorinatedbactobolins,
the major analogs (1 and 2) contain a hydroxyl group at
this position, while the minor analogs (3 and 4)d on o t .
However,neitherofthemonochlorinatedbactobolinsthat
could be detected (7 and 8) contained a hydroxyl group at
this position. These results suggest that the hydroxylase
enzymeBtaUmaybespecificforadichlorinatedbactobolin
substrate.
Thestudiesaboveshowthatthebactobolinbiosynthetic
cluster produces a small family of bactobolins, and the
Figure 2. Bactobolin gene cluster and a proposed biosynthetic model. (A) Schematic of the bactobolin gene cluster. Genes involved in
regulation (orange), metabolite/product transport (green), synthesis of OH-Cl2-Val (dark gray), synthesis of Ala-Ala (light gray),
synthesis of the C6-polyketide and ensuing reactions (blue), tailoring reactions (red), and genes of unknown function (white) are
detailed. The domain architectures for the PKS and NRPS genes are also shown. (B) Proposed bactobolin biosynthesis.
3c See text
for a description.
(13) Marfey, P. Carlsberg Res. Commun. 1984, 49, 591–596.
(14) (a) Shaw-Reid, C. A.; Kellerher, N. L.; Losey, H. C.; Gehring,
A.M.;Berg,C.;Walsh,C.T.Chem.Biol.1999,6,385–400.(b)Gaitatzis,
N.; Kinze, B.; M€ uller, R. Proc. Natl. Acad. Sci. U.S.A. 2001, 98,
11136–11141. (c) Wenzel, S. C.; Kunze, B.; H€ ofle, G.; Silakowski, B.;
Scharfe, M.; Bl€ ocker, H.; M€ uller, R. ChemBioChem 2005, 6, 322–330.
(d) Blodgett, J. A.; Oh, D. C.; Cao, S.; Currie, C. R.; Kolter, R.; Clardy,
J.Proc.Natl.Acad.Sci.U.S.A.2010,107,11692–11697.(e)Dimise,E.J.;
Widboom, P. F.; Bruner, S. D. Proc. Natl. Acad. Sci. U.S.A. 2008, 105,
15311–15316.
(15) (a) Vimr, E. R.; Green, L.; Miller, C. G. J. Bacteriol. 1983, 153,
1259–1265. (b) Barrett, A. J.; Brown, M. A. Biochem. J. 1990, 271, 701–
706.
(16) Hori, M.; Suzukake, K.; Ishikawa, C.; Asakura, H.; Umezawa,
H. J. Antibiot. 1981, 34, 465–468.
(17) Antosz, F. J.; Nelson, D. B.; Herald, D. L., Jr.; Munk, M. E.
J. Am. Chem. Soc. 1970, 92, 4933–4942.Org. Lett., Vol. 13, No. 12, 2011 3051
sources of this diversity lie in the variable number of
alanineresiduesincorporated(BtaKorBtaN),thenumber
of chlorine substituents on valine (BtaC), and the hydro-
xylation at C-5 (BtaU).
To examine the structure activity relationships for
the bactobolin family (1 8), they were tested against
B. subtilis and E. coli. Interestingly, 3 and 7 displayed
similarly weak activities (minimal inhibitory concentra-
tion, MIC, of 50 μg/mL vs B. subtilis)a sd i d4 and 8
(Supporting Information, Figure S7) indicating that the
second chlorine atom has little effect on the antibiotic
activityofthesecompounds(Figure4).Incontrast,5and6
were inactive, as expected based on the potency of 4 and
2.
3c Similar assays with 9 indicate that it is 20-fold less
potent than 1.
16 The difference is provided by the dichlor-
omethyl group present in 1 and absent in 9,i nw h i c h
threonine replaces the modified valine (Figure 1.).
17 The
evolution of OH-Cl-Val and OH-Cl2-Val incorporation in
the Burkholderia lineage, rather than the threonine found
in actinobolin, generated a more potent family of anti-
biotics. Hydroxylation by BtaU further increases the
potency of 1 (MICs of 1.56 μg/mL vs B. subtilis) relative
to those of 3 and 7 (Supplementary Table S5).
In summary, we have identified four new bactobolins,
proposed functions for several important enzymes in-
volved in bactobolin biosynthesis using gene deletion
studies, and identified the structure-diversifying elements
in bactobolin biosynthesis. Additional studies will be
needed to completely define the intriguing steps involved
in bactobolin production.
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Figure 3. Metabolic profile of ΔBtaU B. thailandensis. (A) Ion-
extracted HPLC-MS trace of partially purified culture super-
natant from wt B. thailandensis (black trace for 1, gray trace for
3) and ΔBtaU B. thailandensis (brown trace for 1, orange trace
for 3). (B) Putative reaction catalyzed by BtaU. (C) Proposed
biosynthesis of OH-Cl2-Val based on the results herein. OH-Cl-
Val is made in an analogous fashion, where BtaC adds a single
Cl. The order of reactions by BtaC and BtaA is not known.
Figure4. Inhibitoryactivityof1,3,and7againstB.subtilisBS3610
(A) and E. coli K12 (B).